Summary of endometrial cancer cases after endometrial ablation (n=38)
| Number of endometrial carcinoma cases, N | Percentage of endometrial carcinoma cases/total (%) | |
| Total cases | 38 | |
| Ablation methods | 32 | |
| Resectoscope | 9 | 28 |
| Roller-ball | 5 | 16 |
| (not specified) Hysteroscopic | 6 | 19 |
| Endometrial ablation | ||
| (not specified) Non-hysteroscopic | 1 | 3 |
| Endometrial ablation | ||
| Thermal balloon | 4 | 13 |
| Radio-frequent endometrial ablation | 4 | 13 |
| Mix of methods | 3 | 9 |
| Risk factors | 20* | * |
| (Morbid) obesity | 13 | 65 |
| Diabetes mellitus | 4 | 20 |
| Hypertension | 6 | 30 |
| History of cancer | 2 | 10 |
| Nulliparity | 1 | 5 |
| Estrogen/hormone replacement therapy | 2 | 10 |
| Polycystic ovary syndrome | 1 | 5 |
| None | 4 | 20 |
| Symptoms | 24* | * |
| Vaginal bleeding | 17 | 71 |
| Pelvic pain | 5 | 21 |
| Asymptomatic | 2 | 8 |
| Diagnostic tools | 21* | * |
| Pelvic examination | 2 | 10 |
| Ultrasound | 9 | 43 |
| Hysteroscopy | 9 | 43 |
| Hydrosonography | 1 | 5 |
| Successful endometrial biopsy | 16 | 76 |
| Unsuccessful endometrial biopsy | 2 | 10 |
| Cervix cytology | 2 | 10 |
| CT scan | 1 | 5 |
| Type and stage of cancer (FIGO) | 20 | |
| Endometrioid adenocarcinoma stage I | 18 | 90 |
| Endometrioid adenocarcinoma stage II/III | 1 | 5 |
| Endometrioid adenocarcinoma stage III | 0 | 0 |
| Villoglandular adenocarcinoma | 1 | 5 |
*The sum of these percentages is not 100%, due to multi possible answers.
FIGO, International Federation of Gynecology and Obstetrics.